The presence of specific patterns called centrilobular ground-glass opacifications (cGGOs) in high-resolution computed tomography (HRCT) lung scans is associated with…
Articles by Marta Figueiredo, PhD
Pulmonary thromboendarterectomy (PTE) quickly and significantly improved blood flow dynamics and right-sided heart function in people with chronic…
The blood levels of two molecules involved in vascular remodeling, a hallmark feature of pulmonary arterial hypertension (PAH), may…
Bilateral lung transplant rapidly and effectively normalizes right ventricular function of the heart in children with severe pulmonary arterial hypertension (PAH)…
People with chronic thromboembolic pulmonary hypertension (CTEPH) have significantly worse quality of life at their initial assessment, and higher…
In people experiencing a pulmonary embolism, higher-than-normal arterial stiffness at the time of hospital discharge increased the risk of…
TPN171H, an experimental oral therapy for pulmonary arterial hypertension (PAH), was generally safe and showed a favorable pharmacological profile in…
The Center for Innovative Technology (CIT) GAP Funds has invested in OxiWear and its ear-wearable device designed to continuously…
A combination of lung injury and increased activation of B-cells — immune cells responsible for antibody production — was sufficient to…
A three-month unsupervised health intervention based on a commercial activity tracker and motivational texts significantly increased daily step counts and…
Keros Therapeutics’ experimental therapy KER-012 prevented increases in the levels of markers for inflammation, fibrosis (scarring), and heart…
Tyvaso (inhaled treprostinil) has become the first treatment approved in the U.S. for people with pulmonary hypertension associated…